Volume 11, Issue 1 (1-2023)                   J. Pediatr. Rev 2023, 11(1): 77-90 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alinia T, Shojaei S, Rahimi Pordanjani S, Barati H, Hovsepian S, Hashemi Nazari S S et al . Safety, Acceptance, and Hesitancy of COVID-19 Vaccines Among High-risk Sub-populations: A Narrative Review. J. Pediatr. Rev 2023; 11 (1) :77-90
URL: http://jpr.mazums.ac.ir/article-1-500-en.html
1- Metabolic liver disease research center, Isfahan University of Medical Sciences, Isfahan, Iran.
2- Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Social Determinants of Health Research Center, Department of Epidemiology and Biostatistics, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
4- Prevention of Cardiovascular Disease Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Safety Promotion and Injury Prevention Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5- Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran , mhpanahi2020@gmil.com
Abstract:   (2040 Views)
To end the new COVID-19 pandemic, most of the world’s population needs to be immune to the virus, protecting individuals from infection, and ultimately ensuring herd immunity at the population level. A variety of COVID-19 vaccines have been developed worldwide for adults and children over the age of 12 years, and the effectiveness of the vaccine in preventing symptomatic diseases and hospitalization is being studied. One of the major obstacles to COVID-19 vaccination that has emerged along with the global immunization program is vaccine hesitation or disapproval. The World Health Organization (WHO) has reported vaccine hesitation as one of the 10 global health threats of 2019. This is also related to COVID-19.The present review, explore the current evidence on COVID-19 vaccination platforms and vaccination efficacy, safety, and adverse effects among strategic sub-populations, including elderly people, people with chronic disease (diabetes, cancer), pregnant and lactating women, children, youth, and vaccination willingness or hesitancy among the target population. 
Full-Text [PDF 559 kb]   (711 Downloads) |   |   Full-Text (HTML)  (385 Views)  
Type of Study: Narrative Review | Subject: Immunology
Received: 2022/10/11 | Accepted: 2022/12/9 | Published: 2023/01/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb